Role of intravitreal brolucizumab with intravitreal rtPA and pneumatic displacement for submacular hemorrhage: A case series

PURPOSE: To evaluate the role of intravitreal injection (IVI) of brolucizumab along with intravitreal recombinant tissue plasminogen activator (rtPA) and C3F8 gas injection for large submacular hemorrhage (SMH) secondary to neovascular age-related macular degeneration (nAMD). OBSERVATIONS: This was...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakraborty, Debdulal, Sheth, Jay U., Mondal, Soumen, Boral, Subhendu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841994/
https://www.ncbi.nlm.nih.gov/pubmed/35198814
http://dx.doi.org/10.1016/j.ajoc.2022.101390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841994/
https://www.ncbi.nlm.nih.gov/pubmed/35198814
http://dx.doi.org/10.1016/j.ajoc.2022.101390

Ejemplares similares